Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data.

For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.

Read more about the Fenebrutinib Trial.

Disclosures can be found at Neurology.org.